Data from a small clinical trial of venetoclax in acute myeloid leukemia (AML) supported an FDA breakthrough therapy designation for use in combination with hypomethylating agents in treatment-…
Ruxolitinib is approved for myelofibrosis due to the occurrence of a high frequency of the JAK2 mutation. However, other mutations are also reported in this indication. The FDA has approved…
Thymic tumors, while rare, are classified as orphan diseases due to their infrequency. Despite their rarity, they are the predominant tumors found in the anterior mediastinal compartment among…
Researchers around the world are exploring different approaches to improve our understanding of cancer. The growing need to understand the molecular mechanism of cancer genesis and progression has…
We all experience some level of stress in our daily lives. However, high levels of chronic stress can negatively impact the human body and can…
STAY INFORMED
Top
